Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amneal, Axsome, Beigene, Biogen, Capricor, Celltrion, Corcept, Genentech, Neurenati, Seres.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Spark Biomedical.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Bavarian, Bioarctic, Carsgen, Celltrion, Eisai, GSK, Latigo, Moderna, Ocugen, Pharmather, Valneva.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Shandon Diagnostics.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ardelyx, Astrazeneca, Bioarctic, Celltrion, Innovent, Sanofi, Takeda.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alk-Abello, Astrazeneca, Bioarctic, Daiichi, Eisai, Eli Lilly, Immunitybio, Janssen Cilag, Johnson & Johnson, Krystal, Novartis, Outlook, Regeneron, Roche, Vertex.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adicet, Ocugen, Sobi.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcutis, Ardelyx, Auron, BMS, Celltrion, Gilead, Glaukos, Indivior, Innovent, Insmed, Invivyd, Opus, Porosome, Pyxis, Regeneron, Takeda, Telix, Teva.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcuro, C2N Diagnostics, Etiometry.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Formycon, Grin, Hyloris, Kashiv, Merck & Co., Mirum, Precigen, Sanofi.